The prescribable drugs with efficacy in experimental epilepsies (PDE3) database for drug repurposing research in epilepsy
- PMID: 29341109
- DOI: 10.1111/epi.13994
The prescribable drugs with efficacy in experimental epilepsies (PDE3) database for drug repurposing research in epilepsy
Abstract
Objective: Current antiepileptic drugs (AEDs) have several shortcomings. For example, they fail to control seizures in 30% of patients. Hence, there is a need to identify new AEDs. Drug repurposing is the discovery of new indications for approved drugs. This drug "recycling" offers the potential of significant savings in the time and cost of drug development. Many drugs licensed for other indications exhibit antiepileptic efficacy in animal models. Our aim was to create a database of "prescribable" drugs, approved for other conditions, with published evidence of efficacy in animal models of epilepsy, and to collate data that would assist in choosing the most promising candidates for drug repurposing.
Methods: The database was created by the following: (1) computational literature-mining using novel software that identifies Medline abstracts containing the name of a prescribable drug, a rodent model of epilepsy, and a phrase indicating seizure reduction; then (2) crowdsourced manual curation of the identified abstracts.
Results: The final database includes 173 drugs and 500 abstracts. It is made freely available at www.liverpool.ac.uk/D3RE/PDE3. The database is reliable: 94% of the included drugs have corroborative evidence of efficacy in animal models (for example, evidence from multiple independent studies). The database includes many drugs that are appealing candidates for repurposing, as they are widely accepted by prescribers and patients-the database includes half of the 20 most commonly prescribed drugs in England-and they target many proteins involved in epilepsy but not targeted by current AEDs. It is important to note that the drugs are of potential relevance to human epilepsy-the database is highly enriched with drugs that target proteins of known causal human epilepsy genes (Fisher's exact test P-value < 3 × 10-5 ). We present data to help prioritize the most promising candidates for repurposing from the database.
Significance: The PDE3 database is an important new resource for drug repurposing research in epilepsy.
Keywords: animal models; crowdsourcing; database; epilepsy; literature mining; repurposing.
Wiley Periodicals, Inc. © 2018 International League Against Epilepsy.
Similar articles
-
Identifying new antiepileptic drugs through genomics-based drug repurposing.Hum Mol Genet. 2017 Feb 1;26(3):527-537. doi: 10.1093/hmg/ddw410. Hum Mol Genet. 2017. PMID: 28053048
-
The Seizure-Associated Genes Across Species (SAGAS) database offers insights into epilepsy genes, pathways and treatments.Epilepsia. 2022 Jun 29;63(9):2403-12. doi: 10.1111/epi.17352. Online ahead of print. Epilepsia. 2022. PMID: 35767389 Free PMC article.
-
Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs.Seizure. 2011 Jun;20(5):359-68. doi: 10.1016/j.seizure.2011.01.003. Epub 2011 Feb 2. Seizure. 2011. PMID: 21292505 Review.
-
Critical re-evaluation of previous preclinical strategies for the discovery and the development of new antiepileptic drugs.Epilepsy Res. 2002 Jun;50(1-2):17-20. doi: 10.1016/s0920-1211(02)00064-5. Epilepsy Res. 2002. PMID: 12151113
-
Identifying mutations in epilepsy genes: Impact on treatment selection.Epilepsy Res. 2019 May;152:18-30. doi: 10.1016/j.eplepsyres.2019.03.001. Epub 2019 Mar 4. Epilepsy Res. 2019. PMID: 30870728 Review.
Cited by
-
From the Molecular Mechanism to Pre-clinical Results: Anti-epileptic Effects of Fingolimod.Curr Neuropharmacol. 2020;18(11):1126-1137. doi: 10.2174/1570159X18666200420125017. Curr Neuropharmacol. 2020. PMID: 32310049 Free PMC article. Review.
-
Using common genetic variants to find drugs for common epilepsies.Brain Commun. 2021 Dec 4;3(4):fcab287. doi: 10.1093/braincomms/fcab287. eCollection 2021. Brain Commun. 2021. PMID: 34988442 Free PMC article.
-
Identification of CYFIP2 Arg87Cys Ligands via In Silico and In Vitro Approaches.Biomedicines. 2024 Feb 21;12(3):479. doi: 10.3390/biomedicines12030479. Biomedicines. 2024. PMID: 38540093 Free PMC article.
-
Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression.Epilepsy Curr. 2020 Jan-Feb;20(1_suppl):14S-22S. doi: 10.1177/1535759719895274. Epub 2020 Jan 15. Epilepsy Curr. 2020. PMID: 31937124 Free PMC article.
-
Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies.Nat Commun. 2018 Dec 10;9(1):5269. doi: 10.1038/s41467-018-07524-z. Nat Commun. 2018. PMID: 30531953 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical